首页> 外文期刊>ESC Heart Failure >Implantation of a left ventricular assist device to provide long-term support for end-stage Duchenne muscular dystrophy-associated cardiomyopathy
【24h】

Implantation of a left ventricular assist device to provide long-term support for end-stage Duchenne muscular dystrophy-associated cardiomyopathy

机译:植入左心室辅助装置可为晚期杜氏肌营养不良症相关的心肌病提供长期支持

获取原文
           

摘要

Abstract A young man with Duchenne muscular dystrophy presented to the UT Southwestern Neuromuscular Cardiomyopathy Clinic with advanced heart failure. Despite maximal medical therapy, his cardiac function continued to decline requiring initiation of inotrope therapy. Given the patient's clinical deterioration, a left ventricular assist device (LVAD) was implanted as destination therapy after undergoing a multidisciplinary assessment. The patient tolerated the surgical implantation of the LVAD without any significant complications, and he has had a relatively unremarkable course 38 months post-LVAD implantation. A critical factor contributing to the long-term success of this patient was the decision to select an LVAD that would not disrupt the diaphragm and thus preserve the respiratory muscle strength. This case demonstrates that permanent mechanical LVADs should be considered for appropriately selected Duchenne muscular dystrophy patients with medically refractory end-stage cardiomyopathy.
机译:摘要一名患有Duchenne肌营养不良症的年轻人出现在UT西南神经肌肉心肌病诊所,并伴有严重心力衰竭。尽管进行了最大程度的药物治疗,他的心脏功能仍持续下降,需要开始进行正性肌力疗法。鉴于患者的临床状况恶化,经过多学科评估后,植入了左心室辅助装置(LVAD)作为目的地疗法。该患者耐受LVAD的手术植入,没有任何明显的并发症,并且LVAD植入后38个月的病程相对不明显。决定该患者长期成功的关键因素是决定选择不会破坏横diaphragm膜并因此保留呼吸肌力量的LVAD。这种情况表明,永久机械LVADs应考虑适当选择杜氏肌营养不良症患者的难治性终末期心肌病。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号